WINNIPEG, March 19, 2018 /PRNewswire/ – Medicure Inc. (“Medicure” or the “Company”) (TSXV:MPH, OTC:MCUJF), a cardiovascular pharmaceutical company, today announced that it has placed its PREXXARTAN® (valsartan) oral solution project on hold pending the resolution of a dispute that…
